EMA Set To Discuss Safety Of Ranitidine
Follows US Announcement That Zantac And Generics Must Be Withdrawn
Executive Summary
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.